2006 showed sustained GH and IGF-1 elevation lasting up to 8 days after a single DAC dose [1] Baseline labs / IGF-1, fasting glucose, HbA1c, lipid panel, hepatic panel, PSA (men), TSH Monitoring cadence / Labs at baseline, 6 weeks, 12 weeks, then every 12 weeks while on therapy IGF-1 target / Upper half of age-adjusted reference range
This means that medications like Ozempic, Mounjaro, and Trulicity are typically covered by Medicaid for those indications
A secondary as-treated analysis for continuous use was performed
Out of all the study participants, 39.6 percent were prescribed semaglutide for type 2 diabetes, 42.6 percent were prescribed liraglutide for type 2 diabetes, 11.1 percent were prescribed semaglutide for obesity, and 6.7 percent were prescribed liraglutide for obesity